Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Expert Opinion on Drug Safety|December 11, 2020
Tafenoquine: a toxicity overviewCindy S Chu, Jimee HwangFrontiers in Pharmacology|April 1, 2021
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other DrugsGermana Bancone, Cindy S ChuExpert Review of Anti-Infective Therapy|August 18, 2016
Management of relapsing Plasmodium vivax malariaCindy S Chu, Nicholas J WhitePlos Medicine|April 23, 2021
The prevention and treatment of Plasmodium vivax malariaCindy S Chu, Nicholas J WhiteJournal of Travel Medicine|April 4, 2019
Tafenoquine and G6PD: a primer for cliniciansCindy S Chu, David O FreedmanAntimicrobial Agents and Chemotherapy|April 18, 2018
Characterizing Blood-Stage Antimalarial Drug MIC Values In Vivo Using Reinfection PatternsJames Watson, Cindy S Chu, Joel Tarning, et al.Malaria Journal|March 4, 2018
Primaquine-induced haemolysis in females heterozygous for G6PD deficiencyCindy S Chu, Germana Bancone, François Nosten, et al.Wellcome Open Research|May 14, 2019
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysisCindy S Chu, Germana Bancone, Nay Lin Soe, et al.Plos Neglected Tropical Diseases|April 21, 2018
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malariaJames Watson, Walter R J Taylor, Germana Bancone, et al.The American Journal of Tropical Medicine and Hygiene|November 21, 2019
Declining Burden of Plasmodium vivax in a Population in Northwestern Thailand from 1995 to 2016 before Comprehensive Primaquine Prescription for Radical CureCindy S Chu, Verena I Carrara, Daniel M Parker, et al.Pageof 7